Patient’s Brain Swelling, Death After Taking Aduhelm Under Investigation
The newly approved, if controversial, Alzheimer's drug Aduhelm is in the news after a patient who'd taken the medication was hospitalized for brain swelling and then died. The drug's maker Biogen is investigating if there is any link. Meanwhile, a trial finds psilocybin is useful for combatting depression.